Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Salvage Androgen Deprivation Therapy Use After Definitive Radiotherapy With vs Without Androgen Deprivation Therapy in Prostate Cancer.

The Prostate·2026

Same author

Mortality in Castration Resistant Prostate Cancer Patients With and Without Pre-Existing Cardiovascular Disease Receiving Oral Androgen Receptor Pathway Inhibitors.

Pharmacoepidemiology and drug safety·2026

Same author

Biologically Effective Dose-Optimized Multi-Intensity-Modulated Proton Therapy: A Biologically Comparable Alternative to Proton Arc Therapy.

International journal of particle therapy·2026

Same author

Lattice peak optimization: a mixed-integer framework for geometry-adaptive lattice radiotherapy.

Physics in medicine and biology·2026

Same author

Spatial Dosimetric-Based Prediction of Long-Term Urinary Toxicity After Permanent Prostate Brachytherapy.

Cancers·2026

Same author

Feasibility of proton ultra-high-dose-rate spatially fractionated radiotherapy system for preclinical experiments on a compact proton synchrocyclotron.

Physics in medicine and biology·2026

Search research articles

Related Experiment Video

Updated: May 2, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Optimizing normal tissue sparing via spatiotemporal optimization under equivalent tumor-radical efficacy.

Nimita Shinde¹, Wangyao Li¹, Ronald C Chen¹

¹Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, KS, United States of America.

Physics in Medicine and Biology

|June 13, 2025

Summary

This summary is machine-generated.

This study introduces a novel spatiotemporal optimization model for radiation therapy, ensuring sufficient tumor cell kill while minimizing dose to healthy organs. The model optimizes radiation fractionation based on tumor growth dynamics for personalized treatment planning.

Keywords:

biologically effective dose (BED)intensity-modulated proton therapy (IMPT)spatiotemporal optimization

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

Related Experiment Videos

Last Updated: May 2, 2026

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

Area of Science:

Radiation Oncology
Medical Physics
Computational Biology

Background:

Traditional radiation therapy optimization maximizes tumor dose but may compromise tumor kill.
Spatiotemporal optimization aims to balance target dose and organ-at-risk (OAR) sparing.
Tumor proliferation dynamics (lag time, doubling time) significantly impact treatment outcomes.

Purpose of the Study:

To develop a spatiotemporal optimization model for proton therapy.
To ensure adequate biologically effective dose (BED) for tumor cell kill.
To minimize BED delivered to OARs, considering tumor proliferation.

Main Methods:

A novel spatiotemporal optimization model was formulated for proton therapy.
Incorporated an inequality constraint to guarantee sufficient tumor BED.
Accounted for tumor lag time and doubling time in dose fractionation optimization.

Main Results:

The model consistently met minimum BED requirements for tumor cell kill across tested scenarios.
Mean BED to OARs varied with tumor proliferation dynamics.
Optimal fractionation strategies were identified for prostate (approx. 20 fractions) and head-and-neck cases.

Conclusions:

The proposed model effectively determines optimal radiation fractionation strategies.
It minimizes OAR dose while ensuring tumor cell kill, personalized by tumor growth rates.
This approach offers a versatile tool for advanced clinical treatment planning.